Search Results - "Boyapati, R."

Refine Results
  1. 1

    Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications by Boyapati, R K, Rossi, A G, Satsangi, J, Ho, G-T

    Published in Mucosal immunology (01-05-2016)
    “…Endogenous damage-associated molecular patterns (DAMPs) are released during tissue damage and have increasingly recognized roles in the etiology of many human…”
    Get full text
    Journal Article
  2. 2

    We need to drive change for the future and support junior trainees whilst maintaining the highest training standards by Boyapati, R., Glen, P., Garg, M.

    “…The oral and maxillofacial surgery (OMFS) community in the UK has always felt distinguished to be the only surgical specialty requiring dual qualification…”
    Get full text
    Journal Article
  3. 3

    Applications of teledentistry: A literature review and update by Jampani, N. D., Nutalapati, R., Dontula, B. S. K., Boyapati, R.

    “…Teledentistry is a combination of telecommunications and dentistry involving the exchange of clinical information and images over remote distances for dental…”
    Get full text
    Journal Article
  4. 4

    Aetiology, prevalence, fracture site and management of maxillofacial trauma by Kanala, S, Gudipalli, S, Perumalla, P, Jagalanki, K, Polamarasetty, P V, Guntaka, S, Gudala, A, Boyapati, R P

    “…Maxillofacial fractures are often associated with severe morbidity, functional deficit, disfigurement and significant financial implications. The aim of this…”
    Get full text
    Journal Article
  5. 5

    MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation by Ho, G-T, Aird, R E, Liu, B, Boyapati, R K, Kennedy, N A, Dorward, D A, Noble, C L, Shimizu, T, Carter, R N, Chew, E T S, Morton, N M, Rossi, A G, Sartor, R B, Iredale, J P, Satsangi, J

    Published in Mucosal immunology (01-01-2018)
    “…The multidrug resistance-1 ( MDR1 ) gene encodes an ATP-dependent efflux transporter that is highly expressed in the colon. In mice, loss of MDR1 function…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis by Philpott, H. L., Nandurkar, S., Thien, F., Bloom, S., Lin, E., Goldberg, R., Boyapati, R., Finch, A., Royce, S. G., Gibson, P. R.

    Published in Internal medicine journal (01-09-2015)
    “…Background Eosinophilic esophagitis (EoE) is a newly recognised condition that is apparently increasing in prevalence, and the aetiology is poorly understood…”
    Get full text
    Journal Article
  10. 10

    Verruciform Xanthoma of the Oral Mucosa: A Series of Eight Typical and Three Anomalous Cases by Barrett, A. W., Boyapati, R. P., Bisase, B. S., Norris, P. M., Shelley, M. J., Collyer, J., Sneddon, K. J., Gulati, A.

    “…In this series, there are 8 typical verruciform xanthomas of the oral mucosa and 3 anomalies, 1 polypoid, 1 florid, and 1 carcinomatous. All were characterized…”
    Get full text
    Journal Article
  11. 11

    Impact of the SARS-CoV-2 (COVID-19) crisis on surgical training: global survey and a proposed framework for recovery by Yiasemidou, M, Tomlinson, J, Chetter, I, Biyani, Chandra Shekhar

    Published in BJS open (01-03-2021)
    “…Abstract Background The SARS-CoV-2 pandemic had a profound impact on surgical services, potentially having a detrimental impact on training opportunities. The…”
    Get full text
    Journal Article
  12. 12

    Patients undergoing primary surgery for oral and oropharyngeal cancer: how many are referred on the two-week wait pathway and by whom? by Patel, S, Boyapati, R P, Gulati, A, Barrett, A W

    “…Available data suggest that the two-week wait referral pathway is ineffective at expediting diagnosis of cancer due to large numbers of inappropriate…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    P430 European clinician perspective on withdrawing immunosuppression by Boyapati, R, Fehily, S R, Ding, N S

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Treating to target in inflammatory bowel disease is achieved through early immunosuppression with rapid escalation to combination therapy…”
    Get full text
    Journal Article
  18. 18

    P440 Prevalence of NUDT15 polymorphisms and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease patients: A systematic review and meta-analysis by Yu, N, Sriranganathan, D, Walker, G J, Sazonovs, A, Wilding, H, Kennedy, N A, Ahmad, T, Boyapati, R K, Segal, J P, Ding, N J S

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background Nudix hydrolase 15 (NUDT15) genetic polymorphisms confer an increased risk of thiopurine-induced myelosuppression (TIM). Thiopurines…”
    Get full text
    Journal Article
  19. 19
  20. 20